Industry: The "bubble" of innovative drugs will burst, and a large number of Biotech companies may disappear
Time of Update: 2022-05-11
[Pharmaceutical Network Market Analysis] In recent years, with the continuous introduction of domestic policies to support pharmaceutical innovation, China's innovative drug industry has ushered in r
The State Drug Administration issued an announcement on the implementation of the "Regulations on the Supervision and Administration of Medical Devices" and other matters
Time of Update: 2021-07-31
2. Regarding medical device registration and filing management Starting from June 1, 2021, before the relevant provisions of the new "Regulations" supporting registration and filing are issued and implemented, medical device registration applicants and filing persons will continue to apply for registration and filing in accordance with the current regulations .
Nat Med: Release of Phase III clinical trial results of ecstasy in the treatment of post-traumatic stress disorder PTSD
Time of Update: 2021-05-21
Post-traumatic stress disorder (PTSD) refers to an individual experiencing, witnessing or encountering one or more actual deaths involving himself or others, or being threatened with death, or severe injuries, or threats to physical integrity.
The first CAR-T in China is coming! Fosun Kate Aquilonsai injections are about to be approved
Time of Update: 2021-03-06
From NMPA's official website, Aquilonsai Injection, codentag FKC876, Fosun Kate introduced YESCARTA (Axicabtagene Ciloleucel) technology from Kite Pharma in the United States and is authorized to localize the production of targeted CD19 self-contained CAR-T cell therapy products in China.
Kingsley affiliate Legend has again released CAR-T clinical data with a total remission rate of 97 percent, and researchers expect to use it for more front-line treatments
Time of Update: 2020-12-15
Sidaki Oronse is a new class 1 drug used in the treatment of bio-products by Legendary Bios, a chime antigen-treated T-cell (CAR-T) therapy, and a number of clinical studies are currently under way to treat patients with relapsed or refractic multiple myeloma and more front-line patients, consisting of two single-domain antibodies targeting BCMA with a differentiated structure of CAR-T.
Time of Update: 2020-11-28
It has been suggested that, analogous to many other drug substances, the tricyclic drugs exhibit clinical effectiveness within a defined therapeutic concentration range ( 1 – 10 ).
Song Ruixuan, president of the China Drug Promotion Association, said: New drugs can not only focus on health insurance, generic drugs do not fry too quickly
Time of Update: 2020-11-09
: The number of innovative drug companies participating in the national health care catalog adjustment negotiations this year may be more, fierce competition, but also to maintain a reasonable profit margin of drugs?
45 anti-cancer drugs, 14 rare disease drugs, a big wave of imported drugs to reduce prices
Time of Update: 2020-11-01
In April 2018, the four departments issued the First Notice on the Value-Added Tax Policy on Anti-Cancer Drugs, and as of May 1, 2018, vat-added tax general taxpayers may choose to pay VAT at a simple rate of 3% in accordance with the simple method for the production, sale and wholesale and retail of anti-cancer drugs.
"Pharmaceutical Express" Kangmei management "blood change" drug recall management measures for comments
Time of Update: 2020-10-23
October 13, 2020 / Medical Information At a Glance: Conme management "changed blood" after the state-owned company entered the administration; drug recall management measures for comments; Lilly and Johnson and Johnson announced the latest clinical results of il-23 inhibitors for the treatment of Crohn's disease; Sanofi Dupixent treatment of children with moderate severe asthma Phase III research success ...
Accelerating international integration China's drug registration will move towards the era of eCTD
Time of Update: 2020-10-12
On September 21, 2020, the official website of the State Drug Administration, CDE, issued the Notice on The Re-Public Request for Comments on the Electronic General Technical Document (eCTD) of Pharma
Food safety regulatory innovation: from "people-sea tactics" to "smart supervision" transformation
Time of Update: 2020-09-24
May 2016, Anhui Province introduced a risk rating management system to rate food enterprises and implement classification supervision according to their safety rating.
Aceh Pharmaceutical Bcl-2 inhibitor APG-2575 has been approved by the FDA orphan drug for the treatment of chronic lymphocytic leukemia
Time of Update: 2020-09-20
Introduction: Aceh Pharmaceutical Bcl-2 inhibitor APG-2575 has been qualified by the FDA orphan drug for the treatment of chronic lymphocytic leukemia (CLL).
HK) today announced that the U.S. Food and Drug Administration (FDA) has awarded the company the qualification of the original innovative drug Bcl-2 inhibitor APG-2575 orphan drug for the treatment of chronic lymphocytic leukemia (CLL).
A batch of antimicrobial drugs will be removed from the network hospital can not be sold
Time of Update: 2020-08-01
the Implementation Plan for Special Centralized Procurement of Antibacterial Drugs in Public Medical Institutions in Hunan Province in 2019, the unsuccessfully successful approved consistent evaluation of drugs, patent-expired drugs and reference preparations, allowing them to enter the list of linked networks according to enterprise quotations.
China MNPA approves cell therapy GC007g for CD19 positive relapse difficult to treat B-cell acute lymphoblastic leukemia IND
Time of Update: 2020-06-22
Gracell, a clinical-phaseed cell and gene therapy company, recently announced that the National Drug Administration of China (NMPA) has approved the application of GC007g for a new research drug (IN
Novartis multiple sclerosis Class 1 new drug Sinimod tablets approved for listing in China
Time of Update: 2020-05-13
REVIEW: Orphan "multiple sclerosis" of new drugs coming! According to Chi medicine has learned that May 11, the State Food and Drug Administration announced approval of a Class 1 drug innovation Fu